Govt Job for M.Pharm to work in ICMR funded project

The Birla Institute of Technology & Science, BITS Pilani is an all-India Institute for higher education. The primary motive of BITS is to “train young men and women able and eager to create and put into action such ideas, methods, techniques and information”.

The Institute is a dream come true of its founder late Mr G.D.Birla – an eminent industrialist, a participant in Indian freedom struggle and a close associate of the Father of Indian Nation late Mr. Mohandas Karamchand Gandhi (Mahatma Gandhi).

Applications are invited from suitable candidates for Junior Research Fellow (JRF) to work on the following project sponsored by ICMR, under the supervision of Prof. Rajeev Taliyan, Department of Pharmacy, BITS-Pilani, Pilani Campus, Rajasthan

Title of the project : Exploring the mechanism(s) of gut microbiota link to Parkinson Disease pathology and its reversal based on fibroblast growth factor 21 gene delivery through lentivirus system

Fellowship amount : 31000/- per month

Eligibility requirements : M.Pharm / M.S. (Pharm.) in Pharmacology / Pharmaceutics, Pharmaceutical technology and Pharm. Analysis with GATE / GPAT / CSIR-NET / DST-INSPIRE or equivalent examination.

Duration of the project : 03 Years

Interested candidates with the above mentioned qualification can send the applications on a plain paper giving detailed information about the educational qualifications, research experience and published research papers if any via email by 18th January 2021 to the Principal Investigator, Prof .Rajeev Taliyan [Email: rajeev.taliyan@pilani.bits-pilani.ac.in].

Please note that only qualified and suitable candidates will be called for online interview to be held by end of 3rd week of January 2021 and no TA/DA will be paid for the interview. Selected candidate may be permitted to register for Ph.D programme of BITS, Pilani, subject to the fulfillment of the requirements.

PI : Dr. Rajeev Taliyan (Associate Professor)

Related Posts

Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

The ministry of health and family welfare has declared the Pharmacy Council of India’s (PCI) recently notified regulation on the pharmacist recruitment, promotion and services as ultra vires and does…

Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

NAIROBI/GENEVA— In an alarming development that underscores the accelerating global crisis of antimicrobial resistance, researchers have confirmed the detection of a rare, pan-drug resistant strain of the high-priority fungal pathogen…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

Ministry declares PCI’s regulation on pharmacist recruitment, promotion and services as ultra vires

Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

Second Documented Case of Pan-Drug Resistant Candida auris Uncovered in Kenya

AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

AstraZeneca Pharma India opens new Mumbai corporate office, marking the next phase of growth through innovation

Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

Pharmaceuticals export reports around 4.9 per cent growth in H1 FY27

NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

NDLEA Intercepts Massive ₦6.98 Billion Tramadol Shipment Imported from India at Lagos Port

Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications

Two More Pregnant Women In Rajasthan’s Kota Die From Kidney Complications